Cell entry mechanisms of SARS-CoV-2

Cited by (1,003)

Items 801–900 of 1,003

1. Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
   Hemlata Sharma, Ashal Ilyas, Abhiroop Chowdhury, Nitesh Kumar Poddar, Anis Ahmad Chaudhary, Sireen Abdul Rahim Shilbayeh, Alnada Abdalla Mohamed Ibrahim, Shahanavaj Khan · 2022 · BMC Public Health
2. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection
   Chih-Yun Yang, Yu‐Hsuan Chen, Pei-Jung Liu, Wan‐Chung Hu, Kuo‐Cheng Lu, Kuo‐Wang Tsai · 2022 · International Journal of Medical Sciences
3. Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner
   Meng Chen, Menghang Wang, Xue-Gang Shen, Hao Liu, Yuyuan Zhang, Jinmei Peng, Fandan Meng, Tong-Yun Wang, Yuanzhe Bai, Mingxia Sun et al. · 2022 · Journal of Virology
4. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
   Théophile Cocherie, Karen Zafilaza, Valentin Leducq, Stéphane Marot, Vincent Cálvez, Anne‐Geneviève Marcelin, Ève Todesco · 2022 · Microorganisms
5. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
   Amit Dey, K. Vaishak, Dikshita Deka, Arunkumar Radhakrishnan, Sujay Paul, Priyadarshini Shanmugam, R Alice Peace Selvabai, Surajit Pathak, Asim K. Duttaroy, Antara Banerjee · 2023 · Infection
6. Uncovering the morphological differences between SARS-CoV-2 and SARS-CoV based on transmission electron microscopy images
   Bakr Ahmed Taha, Yousif Ismail Mohammed Al Mashhadany, Qussay Al-Jubouri, Adawiya J. Haider, Vishal Chaudhary, Retna Apsari, Norhana Arsad · 2023 · Microbes and Infection
7. Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis
   Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, Luca Brambilla, Griffin D. Haas, Aditya Gowlikar, Mohammed Nure Alam Siddiquey, Robert Michael Schilke, Matthew D. Woolard, Hongbo Zhang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
8. Graphene Metasurface-Based Surface Plasmon Resonance Biosensor for Rapid COVID-19 Detection with Machine Learning Optimization
   Jacob Wekalao · 2025 · Plasmonics
9. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections
   Rami A. Al‐Horani · 2020 · American Journal of Cardiovascular Drugs
10. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
    Yu. D. Nechipurenko, Anastasia A. Anashkina, Olga V. Matveeva · 2020 · BIOPHYSICS
11. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
    Sinae Kim, Siyoung Lee, Siyoung Lee, Saerok Shim, Tam T. Nguyen, Jihyeong Hwang, Heijun Kim, Yeo-Ok Choi, Jaewoo Hong, Suyoung Bae et al. · 2020 · Immune Network
12. Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
    Kenana Al Adem, Aya Shanti, Cesare Stefanini, Sungmun Lee · 2020 · Pharmaceuticals
13. Mucin signature as a potential tool to predict susceptibility to COVID‐19
    Mukulika Bose, Bhaskar Mitra, Pinku Mukherjee · 2020 · Physiological Reports
14. Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms?
    Mark C. Ballow, Christopher L. Haga · 2021 · The Journal of Allergy and Clinical Immunology In Practice
15. Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
    Yejin Jang, Jin Soo Shin, Myoung Kyu Lee, Eunhye Jung, Timothy An, Uk-Il Kim, Kyungjin Kim, Meehyein Kim · 2021 · International Journal of Molecular Sciences
16. A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel
    Neta S. Zuckerman, Shay Fleishon, Efrat Dahan Bucris, Dana Bar-Ilan, Michal Linial B, Itay Bar-Or, Victoria Indenbaum, Merav Weil, Yaniv Lustig, Ella Mendelson et al. · 2021 · Vaccines
17. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos
    Stacy Colaco, Karisma Chhabria, Domdatt Singh, Anshul Bhide, Neha Singh, Amit Kumar Singh, Atahar Husein, Anuradha Mishra, Radhey Shyam Sharma, Nancy Ashary et al. · 2021 · Journal of Assisted Reproduction and Genetics
18. Saliva Exhibits High Sensitivity and Specificity for the Detection of SARS-COV-2
    Ibrahim Warsi, Zohaib Khurshid, Hamda Shazam, Muhammad Farooq Umer, Eisha Imran, Muhammad Owais Khan, Paul Desmond Slowey, J. Max Goodson · 2021 · Diseases
19. The Immunological Role of the Placenta in SARS-CoV-2 Infection—Viral Transmission, Immune Regulation, and Lactoferrin Activity
    Iwona Bukowska‐Ośko, Marta Popiel, Paweł Kowalczyk · 2021 · International Journal of Molecular Sciences
20. The Spike of SARS-CoV-2: Uniqueness and Applications
    Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flávia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid Jamaan Alzahrani, Aristóteles Goés‐Neto et al. · 2021 · Frontiers in Immunology
21. SARS-CoV-2 and pathological matrix remodeling mediators
    Imen Guizani, Nesrine Fourti, Wiem Zidi, Moncef Feki, Monia Elasmi · 2021 · Inflammation Research
22. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape
    Francesca Fortini, Francesco Vieceli Dalla Sega, Luisa Marracino, Paolo Severi, Claudio Rapezzi, Paola Rizzo, Roberto Ferrari · 2021 · Biomedicines
23. COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses
    Irina Kiseleva, Ксенафонтов Андрей Дмитриевич · 2021 · Biology
24. The Immune Response to SARS-CoV-2 and Variants of Concern
    Elham Torbati, Kurt L. Krause, James E. Ussher · 2021 · Viruses
25. Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
    Haitao Liu, Chenliang Zhou, Jiao An, Yujiao Song, Pin Yü, Jiadai Li, Chenjian Gu, Dongdong Hu, Yuanxiang Jiang, Lingli Zhang et al. · 2021 · Vaccine
26. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
    Patthara Kongsuphol, Huan Jia, Hoi-Lok Cheng, Yue Gu, B. Shunmuganathan, Ming-Wei Chen, Sing-Mei Lim, S. Ng, P. Tambyah, H. Nasir et al. · 2021 · Communications Medicine
27. Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein
    Anton Shuster, Dany Pechalrieu, Cody B. Jackson, Daniel Abegg, Hyeryun Choe, Alexander Adibekian · 2021 · ACS Chemical Biology
28. Vertical Transmission and Neonatal Outcomes Following Maternal SARS-CoV-2 Infection During Pregnancy
    Margaret H. Kyle, Maha Hussain, Victoria Saltz, Isabelle Mollicone, Mary L. Bence, Dani Dumitriu · 2022 · Clinical Obstetrics & Gynecology
29. A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein
    Subbaian Brindha, Yutaka Kuroda · 2022 · International Journal of Molecular Sciences
30. A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease
    Lisa Douglas, James A Reihill, Melisa W-Y. Ho, Jeffrey M. Axten, Nino Campobasso, Jessica L. Schneck, Alan R. Rendina, Keith Wilcoxen, Lorraine Martin · 2022 · Cell chemical biology
31. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)
    Yingshuang Li, Hua-Cheng Ren, Jian-Hua Cao · 2022 · International Journal of Oncology
32. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
    Jingyu Xiang, Mijia Lu, Min Shi, Xiaogang Cheng, Kristin A. Kwakwa, Jennifer L. Davis, Xinming Su, Suzanne J. Bakewell, Yuexiu Zhang, Francesca Fontana et al. · 2022 · Journal of Virology
33. Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection
    Alexander Junxiang Chen, Timothy Wessler, Katherine Daftari, Kameryn Y. Hinton, Richard C. Boucher, Raymond John Pickles, Ronit Freeman, Samuel K. Lai, M. Gregory Forest · 2022 · Biophysical Journal
34. Endomembrane remodeling in SARS-CoV-2 infection
    Di Chen, Yan G. Zhao, Hong Zhang · 2022 · Cell Insight
35. Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2
    James W. Saville, Alison Berezuk, Shanti Swaroop Srivastava, Sriram Subramaniam · 2022 · Chemical Reviews
36. Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern
    Sylwia D. Tyrkalska, Alicia Martínez‐López, Ana B. Arroyo, Francisco J. Martínez-Morcillo, Sergio Candel, Diana García‐Moreno, Pablo Mesa-del-Castillo, María Luisa Cayuela, Víctoriano Mulero · 2022 · Science Advances
37. Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101)
    Yi‐Chang Su, Guan‐Jhong Huang, Jaung‐Geng Lin · 2022 · Frontiers in Pharmacology
38. Ganoderma lucidum polysaccharides ameliorate lipopolysaccharide-induced acute pneumonia via inhibiting NRP1-mediated inflammation
    Xue-Lian Zhang, Daoshun Wu, Yu Tian, Xiang-Dong Chen, Jin Lan, Fei-Long Wei, Ye Li, Yun Luo, Xiao-Bo Sun · 2022 · Pharmaceutical Biology
39. A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID‐19
    Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida, Jiro Mukai, Kenji Furukawa, Seitaro Ohtsu, Susumu Nakade, Tomohiro Hikima, Miwa Haranaka, Naoto Uemura · 2021 · Clinical and Translational Science
40. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
41. Flavonoids derived from medicinal plants as a COVID ‐19 treatment
    Mentor Sopjani, Francesca Falco, Federica Impellitteri, Valeria Guarrasi, Xuan Nguyen Thi, Miribane Dërmaku‐Sopjani, Caterina Faggio · 2024 · Phytotherapy Research
42. SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
    Xi Li, Ze Mi, Zhenguo Liu, Pengfei Rong · 2024 · Frontiers in Microbiology
43. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
    Patrícia Ribeiro de Carvalho, Pierré Sirois, Patrícia Dias Fernandes · 2020 · Peptides
44. Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection
    Richard B. M. Schasfoort, Jos van Weperen, Margot van Amsterdam, Judicaël Parisot, Jan Hendriks, Michelle Koerselman, Marcel Karperien, Anouk Mentink, Martin L. Bennink, Hans G. Krabbe et al. · 2021 · Biosensors and Bioelectronics
45. MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2
    Kentaro Uemura, Michihito Sasaki, Takao Sanaki, Shinsuke Toba, Yoshimasa Takahashi, Yasuko Orba, William W. Hall, Katsumi Maenaka, Hirofumi Sawa, Akihiko Sato · 2021 · Scientific Reports
46. Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
    Fulvio Perrella, Federico Coppola, Alessio Petrone, Chiara Platella, Daniela Montesarchio, Annarita Stringaro, Giampietro Ravagnan, Maria Pia Fuggetta, Nadia Rega, Domenica Musumeci · 2021 · Biomolecules
47. Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant
    Priya Antony, Ranjit Vijayan · 2021 · Biomolecules
48. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody
    David E. Scheim · 2022 · International Journal of Molecular Sciences
49. GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors
    Jihoon Shin, Shinichiro Toyoda, Atsunori Fukuhara, Iichiro Shimomura · 2022 · Biomedicines
50. Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments
    Sareh Pandamooz, Benjamin Jurek, Carl-Philipp Meinung, Zahra Baharvand, Alireza Sahebi Shahem-abadi, Silke Haerteis, Jaleel A. Miyan, James R. Downing, Mehdi Dianatpour, Afshin Borhani‐Haghighi et al. · 2021 · The Annual Review of Pharmacology and Toxicology
51. Treatment and Control of Hypertension in 2020
    Gregory Curfman, Howard Bauchner, Philip Greenland · 2020 · JAMA
52. Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
    Samuel J. Dicken, Matthew J Murray, Lucy Thorne, Ann‐Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Mphatso D. Kalemera, Machaela Palor, Laura E. McCoy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
53. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan
    Xiang Liu, Helen Mostafavi, Wern Hann Ng, Joseph R. Freitas, Nicholas J. C. King, Ali Zaid, Adam Taylor, Suresh Mahalingam · 2022 · mBio
54. SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
    Sabari Nath Neerukonda, Russell A. Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Lisa Bentley, Ann E. Eakin, Karl J. Erlandson, Leah C. Katzelnick, Carol D. Weiss et al. · 2021 · Viruses
55. Respiratory viruses interacting with cells: the importance of electrostatics
    Daniel Christian Lauster, Nikolaus Osterrieder, Rainer Haag, Matthias Ballauff, Andreas Herrmann · 2023 · Frontiers in Microbiology
56. Antiviral Activity of Carbon Dots: Strategies and Mechanisms of Action
    Plinio Innocenzi, Davide De Forni, Franco Lori · 2024 · Small Structures
57. The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor
    Wernér E.G. Müller, Meik Neufurth, Hadrian Schepler, Shunfeng Wang, Emad Tolba, Heinz Christoph Schröder, Xiaohong Wang · 2020 · Biomaterials Science
58. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
    Loukia Yiangou, Richard P. Davis, Christine L. Mummery · 2020 · Stem Cell Reports
59. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures
    Gajanan Sampatrao Ghodake, Surendra Krushna Shinde, Avinash Ashok Kadam, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Asad Syed, Abdallah Mohamed Elgorban, Najat Marraiki, Dae-Young Kim · 2021 · Biosensors and Bioelectronics
60. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy
    Elyse Latreille, Warren L. Lee · 2021 · Viruses
61. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection
    Miroslava Čuperlović‐Culf, Emma Louise Cunningham, Hossen Teimoorinia, Anuradha Surendra, Xiaobei Pan, Steffany A. L. Bennett, Mijin Jung, Bernadette McGuiness, Anthony Peter Passmore, David Beverland et al. · 2021 · Scientific Reports
62. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19
    Valéria Bumiller‐Bini, Camila F. Oliveira, Tamyres Mingorance Carvalho, Gabriela Canalli Kretzschmar, Letícia Boslooper Gonçalves, Nina Moura Alencar, Miguel Angelo Gasparetto Filho, Márcia Holsbach Beltrame, Angelica Beate Winter Boldt · 2021 · Genetics and Molecular Biology
63. COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults
    Jenny Libeth Jurado, Iván Francisco Álvarez Orozco · 2021 · Frontiers in Pediatrics
64. Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
    Wei Zhu, Zeenat A. Shyr, Donald C. Lo, Wei Zheng · 2021 · Journal of Pharmacology and Experimental Therapeutics
65. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell
    Sarah Ibrahim, Gabriela S. F. Monaco, Emily Kristen Sims · 2021 · Islets
66. Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca2+‐dependent membrane fusion
    Yang Yang, Peng Yang, Cong Huang, Yuming Wu, Zhe Zhou, Xuejun Wang, Shengqi Wang · 2021 · Journal of Medical Virology
67. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic
    Xue Li, Liying Zhang, Si Emma Chen, Weilong Ji, Chang Li, Linzhu Ren · 2021 · Infection Genetics and Evolution
68. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
    Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y. J. Zhang, Mirza S. Baig · 2021 · Drugs in R&D
69. Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases
    Sulagna Bhattacharya, Sakshi Agarwal, Nishith M. Shrimali, Prasenjit Guchhait · 2021 · Molecular Aspects of Medicine
70. Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention
    Nikola Gligorijević, Mirjana Radomirović, Olgica Nedić, Marija Stojadinović, K. S. Urmila, Dragana Stanić-Vučinić, Tanja Ćirković Veličković · 2021 · International Journal of Molecular Sciences
71. Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19
    Zhenhua Lü, Hao‐Wei Zhou, Weikang Wu, Ting Fu, Min Yan, Zhen He, Shiwei Sun, Zhaohua Ji, Zhongjun Shao · 2021 · Frontiers in Cellular and Infection Microbiology
72. ANTIVIRAL EFFECTS OF BACTERIOCIN AGAINST ANIMAL-TO-HUMAN TRANSMITTABLE MUTATED SARS-COV-2: A SYSTEMATIC REVIEW
    Dipta Dey, Tanzila Ismail Ema, Partha Biswas, Sharmin Aktar, Shoeba ISLAM, Urmi Rahman Rinik, Mahmudul Firoz, Shahlaa Zernaz Ahmed, Salauddin Al Azad, Ahsab Rahman et al. · 2021 · Frontiers of Agricultural Science and Engineering
73. Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
    Takashi Nakamura, Norikazu Isoda, Yoshihiro Sakoda, Hideyoshi Harashima · 2022 · Journal of Controlled Release
74. Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference
    Vedat Durmaz, Katharina Köchl, A. Krassnigg, Lena Parigger, Michael Hetmann, Amit Singh, Daniel Nutz, Alexander M. Korsunsky, Ursula Kahler, Centina König et al. · 2022 · Scientific Reports
75. Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule
    Fernando Luís Barroso da Silva, Carolina Corrêa Giron, Aatto Laaksonen · 2022 · The Journal of Physical Chemistry B
76. Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
    Alexandra Ya. Rak, Svetlana Donina, Yana A. Zabrodskaya, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
77. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
    Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie · 2022 · Frontiers in Immunology
78. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
    A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, Fabrizio Mancini, Roger Clemens, Aman Wirakartakusumah, Hui‐Fang Chiu, Chi‐Hua Yen, Sebastiano Porretta, Issac Mathai et al. · 2024 · npj Science of Food
79. Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2
    Kingshuk Panda, Kalichamy Alagarasu, Sarah Cherian, Deepti Parashar · 2021 · The Indian Journal of Medical Research
80. Density estimation of SARS-CoV2 spike proteins using super pixels segmentation technique
    Bakr Ahmed Taha, Qussay Al-Jubouri, Yousif Ismail Mohammed Al Mashhadany, Mohd Hadri Hafiz Mokhtar, Mohd Saiful Dzulkefly Zan, Ahmad Ashrif A. Bakar, Norhana Arsad · 2023 · Applied Soft Computing
81. Compensational role between cathepsins
    Urša Pečar Fonović, Janko Kos, Ana Mitrović · 2024 · Biochimie
82. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
    Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda V. Garner, Cynthia Liu, Dmitrii A. Polshakov, Chris Gessner, Steven Watkins · 2020 · ACS Pharmacology & Translational Science
83. SARS-CoV-2: Zoonotic origin of pandemic coronavirus
    Štefan Vilček · 2020 · Acta Virologica
84. Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses
    Inmaculada Galindo, Urtzi Garaigorta, Fátima Lasala, Miguel Ángel Cuesta-Geijo, Paula Bueno, Carmen Gil, Rafael Bastos Delgado, Pablo Gastaminza, Covadonga Alonso · 2020 · Antiviral Research
85. SARS-CoV-2: a new dimension to our understanding of coronaviruses
    Yusha Araf, Nairita Ahsan Faruqui, Saeed Anwar, Mohammad Jakir Hosen · 2020 · International Microbiology
86. Identification of potential antivirals against SARS-CoV-2 using virtual screening method
    Mohammad Rejaur Rahman, Anik Banik, Ishtiak Malique Chowdhury, Emran Hossain Sajib, Sanchita Sarkar · 2021 · Informatics in Medicine Unlocked
87. MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak
    Monire Jamalkhah, Yasaman Asaadi, Mohammadreza Azangou‐Khyavy, Javad Khanali, Masoud Soleimani, Jafar Kiani, Ehsan Arefian · 2021 · Journal of Translational Medicine
88. Dysregulation of COVID-19 related gene expression in the COPD lung
    the MICA II Studygroup, Alastair Watson, Lisa Öberg, B. Angermann, Cosma Mirella Spalluto, Michael H. Hühn, Hannah Burke, Doriana Cellura, Anna T. Freeman, Daniel Muthas et al. · 2021 · Respiratory Research
89. Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19
    Sonia Laneri, Mariarita Brancaccio, Cristina Mennitti, Margherita-Gabriella De Biasi, Maria Elena Pero, Giuseppe Pisanelli, Olga Scudiero, Raffaela Pero · 2021 · Microorganisms
90. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
    Rey Arturo T. Fernandez, Mark Tristan J. Quimque, Kin Israel Notarte, Joe Anthony Manzano, Delfin Yñigo H. Pilapil, Von Novi de Leon, John Jeric P. San Jose, Omar A. Villalobos, Nisha Harur Muralidharan, M. Michael Gromiha et al. · 2021 · Journal of Biomolecular Structure and Dynamics
91. Interspecies Jumping of Bat Coronaviruses
    Antonio C. P. Wong, Susanna K. P. Lau, Patrick C. Y. Woo · 2021 · Viruses
92. Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains
    Yuan Tian, Lisa M. Parsons, Ewa Anita Jankowska, John F. Cipollo · 2021 · Frontiers in Chemistry
93. Nanotechnology-Based Strategies for Effective and Rapid Detection of SARS-CoV-2
    Koena Leah Moabelo, Darius Riziki Martin, Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Mervin Meyer, Abram Madimabe Madiehe · 2021 · Materials
94. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
    Periklis Katopodis, Harpal Singh Randeva, Demetrios A. Spandidos, Sayeh Saravi, Ioannis Kyrou, Emmanouíl Karteris · 2021 · International Journal of Molecular Medicine
95. Designer DNA nanostructures for viral inhibition
    Shaokang Ren, Keith Fraser, Lili Kuo, Neha Chauhan, Addison T. Adrian, Fuming Zhang, Robert J. Linhardt, Paul S. Kwon, Xing Wang · 2022 · Nature Protocols
96. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2
    İsmail Çeli̇k, Abbas Khan, Fenny Martha Dwivany, Fatimawali Fatimawali, Dong‐Qing Wei, Trina Ekawati Tallei · 2022 · Molecular Diversity
97. Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches
    Maged E. Mohamed, Nora Tawfeek, Samar S. Elbaramawi, Eman Fikry · 2022 · Plants
98. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
    Anna Riccio, Silvia Santopolo, Antonio Rossi, Sara Piacentini, Jean‐François Rossignol, M. Gabriella Santoro · 2022 · Cellular and Molecular Life Sciences
99. Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping
    Yong Zhang, Sabrina Rahman Archie, Yashwardhan Ghanwatkar, Sejal Sharma, Saeideh Nozohouri, Elizabeth Burks, Alexander Mdzinarishvili, Zijuan Liu, Thomas J. Abbruscato · 2022 · Fluids and Barriers of the CNS
100. 1 H qNMR-Based Metabolomics Discrimination of Covid-19 Severity
     Banny Silva Barbosa Correia, Vinícius Guimarães Ferreira, Priscila Marques Firmiano Dalle Piagge, Mariana Bortholazzi Almeida, Nilson Antônio Assunção, Joyce Regina Santos Raimundo, Fernando Luiz Affonso Fonseca, Emanuel Carrilho, Daniel R. Cardoso · 2022 · Journal of Proteome Research